A carregar...
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
New oral anticoagulants (NOACs) is the preferred treatment in secondary prophylaxis of venous thromboembolic events (VTE). The aim of this study was to investigate possible risk factors associated with major bleeding in VTE-patients treated with NOACs. In this retrospective register-based study we s...
Na minha lista:
| Publicado no: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8282556/ https://ncbi.nlm.nih.gov/pubmed/33140837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02319-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|